Finance

Lists
CBHD:ETR
Coloplast A/S
€67.42
+1.32%
(+0.88) 1D
Nov 13, 5:35:43 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CBHD...
Open
€66.40
High
€67.82
Low
€66.38
Mkt. cap
106.78B
Avg. vol.
2.03K
Volume
804.00
52-wk high
€80.90
52-wk low
€49.48
No. of employees
17K
Open
€66.40
High
€67.82
Low
€66.38
Mkt. cap
106.78B
Avg. vol.
2.03K
Volume
804.00
52-wk high
€80.90
52-wk low
€49.48
No. of employees
17K
News stories
From web sources and news partners
Profile
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
About Coloplast A/S
CEO-
Employees17.3K
Founded1957
HeadquartersHumlebaek, Capital Region of Denmark, Denmark
SectorHealth Care
IndustryMedical device
Last report
Nov 3, 2026
Fiscal period
Q4 2026
DKK 5.67 / DKK 5.73
-0.99%miss
Revenue / Est. (DKK)
7.46B / 7.41B
+0.73%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
7.04B
7.08B
7.36B
7.46B
Cost of goods sold
2.31B
2.37B
2.45B
2.57B
Cost of revenue
2.31B
2.37B
2.45B
2.57B
Research and development expenses
247.00M
254.00M
281.00M
285.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.64B
2.67B
2.72B
2.78B
Operating expense
2.88B
2.90B
2.98B
3.04B
Total operating expenses
5.19B
5.26B
5.43B
5.61B
Operating income
1.85B
1.82B
1.93B
1.85B
Other non operating income
42.00M
-188.00M
-
-63.00M
EBT including unusual items
1.79B
-1.24B
1.87B
1.43B
EBT excluding unusual items
1.83B
1.78B
1.89B
1.56B
Income tax expense
394.00M
-273.00M
412.00M
242.00M
Effective tax rate
22.00%
21.95%
21.98%
16.95%
Other operating expenses
-6.00M
-23.00M
-25.00M
-29.00M
Net income
1.40B
-971.00M
1.46B
1.19B
Net profit margin
19.84%
-13.71%
19.88%
15.90%
Earnings per share
-
6.16
-
5.67
Interest and investment income
32.00M
149.00M
169.00M
21.00M
Interest expense
-164.00M
-
-206.00M
-144.00M
Net interest expenses
-132.00M
149.00M
-37.00M
-123.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.20B
2.17B
2.29B
2.22B
Gain or loss from assets sale
-
1.00M
-5.00M
4.00M
Upcoming events
AI content may include mistakes. Learn more
Google apps